TrialNature communications2025

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy.

Kazuki Nozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.